Filing Details
RenovoRx, Inc. (NASDAQ:RNXT) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event.
8k filedNASDAQ:RNXT
RenovoRx, Inc. (RNXT) Reports Material Event to SEC
Filing Details RenovoRx, Inc. (NASDAQ:RNXT) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event. Market Context RenovoRx,…
Market Context
RenovoRx, Inc.'s stock currently trades at $0.92 with a market capitalization of $36.4M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for RenovoRx, Inc.'s stock.
All SEC filings for RenovoRx, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View RNXT Stock Page
Frequently Asked Questions
Where can I read RNXT's SEC filings?
Browse all filings on our RNXT SEC filings page.
What types of SEC filings does RenovoRx, Inc. file?
Public companies like RenovoRx, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.